The effect of Alendronate on bone mineral density in the acetabulum and proximal femur after cementless total hip arthroplasty

The effect of Alendronate on bone mineral density in the acetabulum and proximal femur after cementless total hip arthroplasty - The effect of Alendronate on bone mineral density in the acetabulum and proximal femur after cementless total hip arthroplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004847

Enrollment

Registered

2011-01-15

Start date

2007-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post hip arthroplasty

Interventions

Medication with Alendronate Control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Post hip arthroplasty

Exclusion criteria

Exclusion criteria: Metabolic bone disease except for osteopolosis, taking medications that could affect bone turnover (such as bisphosphonates, active vitamin D3, estrogen, calcitonin, SERM, ipriphrabones, vitamin K), renal disfunction.

Design outcomes

Primary

Measure	Time frame
The change of bone mineral density in the acetabulum and proximal femur	—

Countries

Japan

Contacts

Public ContactYuko Sakamoto

Juntendo University Nerima Hospital Dept. of Orthopaedics

u-sakamo@juntendo.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026